High Net Worth Advisory Group LLC Cyteir Therapeutics, Inc. Transaction History

High Net Worth Advisory Group LLC

  • $358 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022
SELL
$3.39 - $10.51 $1,695 - $5,255
-500 Closed
0 $0
Q4 2021

Aug 10, 2022
BUY
$9.83 - $19.21 $4,915 - $9,605
500 New
500 $6,000
Q4 2021

Apr 27, 2022
BUY
$9.83 - $19.21 $0 - $0
0 New
0 $0

Others Institutions Holding CYT

# of Institutions
2
Shares Held
2.47M
Call Options Held
0
Put Options Held
0
View Full List

About Cyteir Therapeutics, Inc.

CYT Quotes by TradingView
  • Ticker CYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,413,400
  • Market Cap $107M
  • Description
  • Cyteir Therapeutics, Inc., a clinical-stage biotechnology company, develops and commercializes the next-generation of precision oncology medicines. Its lead product CYT-0851, a novel, oral, once-daily, small molecule drug candidate that is in Phase I/II clinical trial for monotherapy in solid tumors and hematologic malignancies, as well as for c...
More about CYT
Track This Portfolio

Track High Net Worth Advisory Group LLC Portfolio

Follow High Net Worth Advisory Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Net Worth Advisory Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Net Worth Advisory Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email